As of 2026-09-14, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (37.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.96 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -389.0%.
The range of the Relative Valuation is (36.79) - (39.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 19.8x | 18.2x |
| Forward P/E multiples | 15.5x - 18.3x | 16.3x |
| Fair Price | (36.79) - (39.75) | (37.45) |
| Upside | -383.9% - -406.7% | -389.0% |
| Date | P/E |
| 2026-09-09 | -6.09 |
| 2026-09-08 | -6.21 |
| 2026-09-04 | -6.48 |
| 2026-09-03 | -6.45 |
| 2026-09-02 | -6.48 |
| 2026-09-01 | -6.21 |
| 2026-08-31 | -6.13 |
| 2026-08-28 | -6.25 |
| 2026-08-27 | -6.35 |
| 2026-08-26 | -6.51 |
| 2026-08-25 | -6.48 |
| 2026-08-24 | -6.48 |
| 2026-08-21 | -6.19 |
| 2026-08-20 | -6.04 |
| 2026-08-19 | -6.21 |
| 2026-08-18 | -6.12 |
| 2026-08-17 | -5.90 |
| 2026-08-14 | -6.05 |
| 2026-08-13 | -6.18 |
| 2026-08-12 | -6.21 |
| 2026-08-11 | -6.22 |
| 2026-08-10 | -6.35 |
| 2026-08-07 | -6.33 |
| 2026-08-06 | -6.14 |
| 2026-08-05 | -6.08 |
| 2026-08-04 | -6.13 |
| 2026-08-03 | -5.96 |
| 2026-07-31 | -5.79 |
| 2026-07-30 | -5.98 |
| 2026-07-29 | -5.73 |
| 2026-07-28 | -5.80 |
| 2026-07-27 | -5.85 |
| 2026-07-24 | -5.88 |
| 2026-07-23 | -5.96 |
| 2026-07-22 | -6.01 |
| 2026-07-21 | -6.17 |
| 2026-07-20 | -6.05 |
| 2026-07-17 | -6.32 |
| 2026-07-16 | -6.07 |
| 2026-07-15 | -6.08 |
| 2026-07-14 | -6.03 |
| 2026-07-13 | -6.27 |
| 2026-07-10 | -6.30 |
| 2026-07-09 | -6.55 |
| 2026-07-08 | -6.66 |
| 2026-07-07 | -6.56 |
| 2026-07-06 | -6.67 |
| 2026-07-02 | -6.95 |
| 2026-07-01 | -6.79 |
| 2026-06-30 | -6.71 |